The U.S. National Institutes of Health agreed to resume scientific review of hundreds of grant applications that had been paused under new administration directives, after litigation by science organizations and individual researchers. The agreement requires NIH to evaluate the stalled applications on scientific merit and to ignore the challenged anti‑diversity directives while the broader legal fight continues. Plaintiffs include the American Public Health Association and researchers such as Nikki Maphis; the deal follows a federal judge’s earlier ruling that certain grant terminations were unlawful. The NIH did not admit wrongdoing or guarantee funding, but agreed to complete consideration of affected applications in the ordinary course of its review process, with a judge overseeing compliance.